Table 2.
Compound | Structure | Clinical trails | Reference |
---|---|---|---|
BLU-945 | Undisclosed | Phase 1 | Schalm et al., 2020 |
BBT-176 | Undisclosed | Phase 1 |
Compound | Structure | Clinical trails | Reference |
---|---|---|---|
BLU-945 | Undisclosed | Phase 1 | Schalm et al., 2020 |
BBT-176 | Undisclosed | Phase 1 |